S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stenocare A/S
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Retained Earnings
kr24.4m
CAGR 3-Years
-22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Retained Earnings
kr120.1B
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
12%
H Lundbeck A/S
CSE:HLUN A
Retained Earnings
kr19.9B
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Retained Earnings
kr4.4B
CAGR 3-Years
11%
CAGR 5-Years
7%
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Retained Earnings?
Retained Earnings
24.4m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Retained Earnings amounts to 24.4m DKK.

What is Stenocare A/S's Retained Earnings growth rate?
Retained Earnings CAGR 3Y
-22%

Over the last year, the Retained Earnings growth was 5%. The average annual Retained Earnings growth rates for Stenocare A/S have been -22% over the past three years .

Back to Top